The objective of the study was to determine the effects of Candida albicans respiratory tract colonization on Acinetobacter baumannii pneumonia in a rat model. Rats were colonized with C. albicans by instillation of 3 ؋ 10 6 CFU into their airways, while sterile saline was instilled in the control group. The colonized rats were further divided into two groups: treated with amphotericin B or not. The rats were subsequently infected with A. baumannii (10 8 CFU by tracheobronchial instillation). A. baumannii lung CFU counts, cytokine lung levels, and rates of A. baumannii pneumonia were compared between groups. In vitro expression of A. baumannii virulence genes was measured by reverse transcription (RT)-PCR after 24-hour incubation with C. albicans or with Mueller-Hinton (MH) broth alone. Rats with Candida colonization developed A. baumannii pneumonia more frequently and had higher A. baumannii CFU burdens and heavier lungs than controls. After A. baumannii infection, lung interleukin 17 (IL-17) concentrations were lower and gamma interferon (IFN-␥) concentrations were higher in Candida-colonized rats than in controls. Candida-colonized rats treated with amphotericin B had a decreased rate of A. baumannii pneumonia and lower IFN-␥ levels but higher IL-17 levels than untreated rats. Expression of basC, barB, bauA, ptk, plc2, and pld2 was induced while expression of ompA and abaI was suppressed in A. baumannii cultured in the presence of C. albicans. C. albicans colonization facilitated the development of A. baumannii pneumonia in a rat model. Among Candida-colonized rats, antifungal treatment lowered the incidence of A. baumannii pneumonia. These findings could be due to modification of the host immune response and/or expression of A. baumannii virulence genes by Candida spp.
C
andida albicans is a commensal of the human skin and mucosae but also the most common fungal human pathogen (1) (2) (3) . Recent data are suggestive of clinically significant interactions between C. albicans and bacteria, potentially affecting their virulence (2, 4, 5) and propensity to develop antibacterial resistance (6) (7) (8) (9) .
Specifically, clinical and laboratory investigations have focused on the interplay between C. albicans and Pseudomonas aeruginosa (10) . In animal models and observational studies, C. albicans airway colonization has been associated with increased incidence of P. aeruginosa pneumonia (11, 12) . Prior antifungal treatment was found to reduce the risk of P. aeruginosa pulmonary infection (11, 13) . However, in burn patients, P. aeruginosa inhibited the growth of Candida spp. on the wound surface (4) .
Acinetobacter baumannii is an emerging nosocomial pathogen associated with significant morbidity and multidrug resistance (14) (15) (16) . A. baumannii can firmly adhere to the hyphae of C. albicans and inhibit their growth via production of the OmpA protein (17) . Nevertheless, A. baumannii exhibited enhanced growth in the presence of another yeast, Saccharomyces cerevisiae (18) .
These observations indicate complex, possibly both synergistic and antagonistic yeast-bacterial interactions that have not been adequately investigated. Therefore, we aimed to study the relationship between C. albicans respiratory tract colonization and bacterial pneumonia caused by A. baumannii in a rat model, as well as the effect of culture in the presence of C. albicans on the expression of A. baumannii virulence genes.
MATERIALS AND METHODS

Animals.
We used 2.5-to 3-month-old pathogen-free male Wistar rats, weighing 250 to 275 g (11) , purchased from the Laboratory Animal Center (Southern Medical University, Guangzhou, China). All experiments were approved by the Ethics of Animal Experiments Committee of Nan Fang Hospital, an affiliate of the Southern Medical University, Guangzhou, China. The rats were housed under standard conditions (12 h light/12 h dark; 22 to 24°C) in the Animal Care Facility Service (Southern Medical University, Guangzhou, China). The study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
C. albicans respiratory tract colonization. Candida colonization was achieved by transglottal instillation of 3 ϫ 10 6 CFU C. albicans SC5314 on the first day of experiments, as previously described (11) . To establish the model, 4 animals were sacrificed at each time point, 4, 24, and 72 h and 7 and 14 days after instillation, and their lungs were removed. The lungs from one animal were homogenized and used for Candida CFU counts, whereas those from the other three were used for histopathologic analyses. We compared lung cytokine levels between Candida-colonized and con-trol rats without A. baumannii infection 48 h after Candida or saline instillation, respectively.
Assessing the effect of C. albicans respiratory tract colonization on A. baumannii pneumonia. Rats were divided into C. albicans respiratory tract colonization (n ϭ 16) and saline control (n ϭ 18) groups. A suspension of 10 8 CFU of A. baumannii ATCC 19606 was transglottally instilled in each animal on the second day of the experiment. At this inoculum, A. baumannii pneumonia develops in Ͻ50% of immunocompetent rats. The animals were sacrificed on the third day. Lung weights, A. baumannii CFU counts, and lung cytokine concentrations were compared between the two groups. Pneumonia was defined as macroscopic and/or microscopic lung inflammation with a bacterial burden of Ͼ10 4 CFU per lung (11) .
Antifungal treatment. The Candida-colonized rats were divided into those treated with 1 mg/kg of body weight/day of intraperitoneal amphotericin B (treatment group; n ϭ 19) or normal saline intraperitoneal injections (control group; n ϭ 16), as previously described (11) , for 3 days after airway colonization with Candida. On the 4th day, the rats were infected with A. baumannii as described above, and on the 5th day, they were sacrificed for lung tissue bacterial CFU and cytokine measurements. In a separate experiment, we compared lung cytokine levels between Candida-colonized rats treated for 3 days with amphotericin B or not and without Acinetobacter infection.
Cytokine measurements. Levels of interleukin 2 (IL-2), IL-5, IL-6, IL-10, IL-17, and gamma interferon (IFN-␥) were determined using the Milliplex Map Rat Cytokine/Chemokine Magnetic Bead panel (Millipore Corporation, USA) on a Luminex (Austin, TX) 100 IS system according to the manufacturer's instructions to evaluate the host local immune response.
In vitro experiments, RNA isolation, and real-time PCR analysis. For in vitro experiments, 1 ml of 5 ϫ 10 8 CFU/ml A. baumannii in Mueller-Hinton (MH) broth suspension was cultured with 1 ml of C. albicans MH broth suspension (3 ϫ 10 7 cells/ml) (Candida) or 1 ml of MH broth (control). After a 24-hour incubation at 37°C, 1 ml was moved to a 1.5-ml tube and centrifuged for 10 min at 5,000 ϫ g to obtain bacterial pellets; 100 l of TE buffer (10 mM Tris · Cl, 1 mM EDTA, pH 8.0) with 1 mg/ml lysozyme was added to the precipitate, which was resuspended and incubated for 5 min at room temperature.
Total A. baumannii mRNA was extracted using an RNeasy Mini RNA isolation kit (Qiagen, Shanghai, China). RNA integrity, concentration, and purity were assessed using a Nanodrop spectrophotometer. Samples with a 260/280-nm ratio between 1.9 and 2.1 were used for further analyses. Any potential carryover genomic DNA (gDNA) contamination was removed using gDNA Eraser (TaKaRa, Dalian, China); 1 g of total RNA was used to synthesize cDNA with the PrimeScript RT reagent kit with gDNA Eraser (Perfect Real Time; TaKaRa, Dalian, China). Quantitative analyses of virulence genes of A. baumannii (ompA, pgaC, lpxA, basC, basD, barB, bauA, ptk, plc2, pld2, and abaI) were performed on a LightCycler 480 real-time PCR system (Roche, Switzerland) using the SYBR Premix Ex Taq II (Tli RNaseH Plus) kit (TaKaRa, Dalian, China).
Using 16S rRNA as the reference gene (19) , reverse transcription (RT)-PCR data from at least 3 independent experiments were analyzed by the 2
Ϫ⌬⌬Ct method. Changes in the expression of A. baumannii virulence genes in the presence of C. albicans were expressed as a ratio relative to the control group.
Statistical analysis. Data were analyzed using SPSS software version 17.0 (SPSS Inc., Chicago, IL, USA). All data are presented as means and standard deviations (SD) unless otherwise specified. Normality of distribution was tested with the Kolmogorov-Smirnoff test. We determined statistical significance (P Ͻ 0.05) by t test, analysis of variance (ANOVA), or Mann-Whitney U test, where appropriate. Roux et al. (11) , the respiratory tracts of Wistar rats were colonized with C. albicans. The 14-day survival of the colonized rats was 100%, and there were no differences in activity, fecal shape, and average daily weight gain between animals colonized with C. albicans and controls (airway instillation of normal saline) (Fig. 1) . We found no histopathologic evidence of pneumonia in Candida-colonized rats.
RESULTS
C. albicans respiratory tract colonization model. On the basis of the model provided by
Candida colonization of the respiratory tract facilitates the development of subsequent A. baumannii pneumonia. Twentyfour hours after lung instillation of A. baumannii, rats with prior C. albicans respiratory tract colonization had higher A. baumannii lung CFU counts (P ϭ 0.026) and lung weights (P ϭ 0.034) than controls ( Fig. 2) . Ten of 16 rats with C. albicans airway colonization developed A. baumannii pneumonia as opposed to 4/18 in the control group (P ϭ 0.017). Two lungs infected with A. baumannii are shown in Fig. 3 . Consolidation is evident in the lung of a Candida-colonized rat (Fig. 3B) . Microscopically, animal lungs colonized with C. albicans prior to A. baumannii infection demonstrated heavier infiltration of inflammatory cells and alveolar damage (Fig. 4D) than lungs with A. baumannii infection in the absence of prior C. albicans colonization (Fig. 4C) .
C. albicans colonization downregulated the effect of A. baumannii on host IL-17 production and upregulated its effect on IFN-␥ production. We measured lung IFN-␥, IL-2, and IL-17 levels in C. albicans-colonized rats and controls in the absence of (48 h after Candida or saline instillation) and 24 h after A. baumannii infection. Levels of IL-17 (41.4 Ϯ 7.0 versus 17.7 Ϯ 4.2 pg/ml; P ϭ 0.01) (Fig. 5A ), IL-2 (84.6 Ϯ 8.3 versus 54.3 Ϯ 7.1 pg/ml; P ϭ 0.02) (Fig. 5B) , and IFN-␥ (130.2 Ϯ 33.9 versus 54.3 Ϯ 10.8 pg/ml; P ϭ 0.005) (Fig. 5C ) were higher in rats colonized with Candida than in controls in the absence of bacterial infection.
In the control group, IFN-␥ (P ϭ 0.002), IL-17 (P Ͻ 0.001), and IL-2 (P ϭ 0.02) concentrations were significantly increased with A. baumannii instillation, whereas in Candida-colonized rats, only IFN-␥ levels were increased with bacterial infection (P Ͻ 0.001). A. baumannii-infected rats with prior C. albicans airway colonization had significantly lower IL-17 (34.9 Ϯ 6.53 versus 47.8 Ϯ 0.7 pg/ml; P ϭ 0.029) (Fig. 5A ) and higher IFN-␥ (480.5 Ϯ 11.7 versus 301.8 Ϯ 97.4 pg/ml; P ϭ 0.011) (Fig. 5C ) concentrations than A. baumannii-infected controls. There was no difference in IL-2 levels (79.8 Ϯ 19.4 versus 67.8 Ϯ 2.8 pg/ml; P ϭ 0.265) (Fig. 5B) .
Effect of antifungal therapy. In rats with C. albicans airway colonization, we studied the effects of systemic amphotericin B (1 mg/kg daily), starting on the day of Candida instillation and administered for 3 days, on the lung fungal burden, subsequent A. baumannii pneumonia, and host cytokine production.
The pulmonary fungal burden was significantly decreased in amphotericin B-treated rats compared to those that did not receive antifungal treatment (P ϭ 0.015) (Fig. 6A) . Fewer rats in the treatment group developed A. baumannii pneumonia (5/19 versus 10/16; P ϭ 0.031). Lung weights (P ϭ 0.027) (Fig. 6B ) and lung tissue Acinetobacter CFU counts (P ϭ 0.038) (Fig. 6C) were also significantly lower in Candida-colonized rats that were treated with amphotericin B than in those that were not.
In Candida-colonized rats without A. baumannii infection, IL-2 ( Fig. 7B ) and IFN-␥ (Fig. 7C ) lung concentrations were decreased with antifungal treatment (P Ͻ 0.05), whereas there was no significant difference in IL-17 levels (Fig. 7A) . After A. baumannii instillation, IL-17 levels were higher (P ϭ 0.005) (Fig. 7D) whereas the concentration of IFN-␥ was lower (P ϭ 0.032) (Fig.  7F) in Candida-colonized rats that received antifungal treatment than in those that did not. IL-2 levels were similar in the two groups (P ϭ 0.693) (Fig. 7E) . We did not find any significant effects of Candida colonization or antifungal treatment on IL-5, IL-6, or IL-10 levels (see Fig. S1 and S2 in the supplemental material).
Effect of C. albicans on expression of A. baumannii virulence genes. The expression of A. baumannii virulence genes was assessed by RT-PCR after 24 h of culture with C. albicans compared to MH broth alone. The primers used in this experiment are listed in Table S1 in the supplemental material. In the presence of C. albicans, the expression of basC, barB, bauA, ptk, plc2, and pld2 was upregulated, whereas the expression of abaI and ompA was suppressed (Table 1) .
DISCUSSION
We studied a simple, reproducible rat model of C. albicans respiratory tract colonization previously described by Roux et al. (11) and extended their findings for the evaluation of C. albicans-A. baumannii (an emerging opportunistic pathogen) coinfection. After instillation, Candida organisms were retrieved from animal lungs with slow clearance over time, 14-day survival was 100%, and there were no differences in weight or health status between Candida-instilled animals and controls (Fig. 1) . These findings are consistent with colonization rather than clinical infection. How- ever, instillation of C. albicans, but not of normal saline, elicited a strong host immune response (Fig. 5 ) similar to that observed previously (11) . Therefore, even though there was no evidence of clinical disease, it seems that C. albicans in the respiratory tract is not just a commensal bystander.
Importantly, we found convincing evidence that C. albicans respiratory tract colonization in rats facilitated the subsequent development of severe A. baumannii infection, as evidenced by higher bacterial CFU counts, lung weights, histopathology (Fig. 2  to 4) , and percentages of animals that developed pneumonia than for controls. To our knowledge, this is the first report of an association between Candida airway colonization and Acinetobacter pneumonia, which is consistent with animal studies (11) and clinical data (12, 13) for other pathogens. Such observations could be due to (i) modification of the host immune response by C. albicans and/or (ii) fungal-bacterial interactions resulting in enhanced bacterial virulence.
As noted above, C. albicans colonization increased IFN-␥ secretion, in agreement with a previous report (11) . In both studies, this effect was completely reversed by administration of antifungal agents (Fig. 7) , which also led to significantly lower rates of bacterial pneumonia, lung weights, and A. baumannii CFU counts (Fig.  6 ). These effects were previously attributed to a strong T H 1 response to the presence of C. albicans (11) , leading to increased levels of IFN-␥. However, it should be noted that innate immune cell populations, such as NK cells, also produce IFN-␥ in the context of pulmonary infection and likely contribute to cytokine production, especially at early time points before priming of T H cells.
IFN-␥ has been shown to hamper host antibacterial defenses. Specifically, overnight incubation with IFN-␥ decreased phagocytosis of Escherichia coli and Staphylococcus aureus by alveolar macrophages by Ͼ90% (11). Moreover, IFN-␥ downregulated the expression of a class A scavenger receptor on the surfaces of alveolar macrophages, thus impairing phagocytosis of Pneumococcus, which was restored to normal by anti-IFN-␥ specific antibodies or opsonization, which bypasses scavenger receptors (20) . Therefore, upregulation of IFN-␥ production is a potential determinant of the increased susceptibility to bacterial infections associated with C. albicans airway colonization.
IL-17 levels were significantly lower in Candida-colonized rats than in controls after A. baumannii instillation, in agreement with previous observations in a rat model of P. aeruginosa pneumonia (11) . Similar to the study by Roux et al. (11), we found no difference in IL-17 lung concentrations between Candida-colonized rats treated with amphotericin B and untreated rats in the absence of A. baumannii instillation. However, in the prior study, the effect of antifungals on IL-17 production in Candida-colonized rats as a response to bacterial infection was not evaluated (11) . Interestingly, in our study, treatment of C. albicans colonization with amphotericin B led to a significant increase in post-A. baumannii instillation IL-17 levels. These findings support the well-described role of IL-17 in host defenses against extracellular bacteria and fungi (21, 22) . Notably, amphotericin B has antifungal as well as immunomodulatory effects, and further studies are needed to determine if our observations are the result of either or both (23) .
In previous studies using the same rat model (11, 24) , C. albicans airway colonization primed the host for development of S. aureus and P. aeruginosa pneumonia; however, the T H 2 lineage did not seem to be activated, in agreement with our results (see Fig. S1 and S2 in the supplemental material). On the other hand, in BALB/c mice, C. albicans intranasal instillation had a beneficial effect on Pseudomonas pneumonia, with increased T H 2 cytokine levels (25) . Therefore, it seems that the interplay between Candida airway colonization, host immune response, and subsequent development of bacterial pneumonia is host dependent. In human cells, where a T H 1-T H 17 response is protective against Candida infections (26), IL-26 was recently identified as a potent mediator of the T H 17 axis antibacterial properties (22) . Since the gene for IL-26 is absent in rodents (21, 22) , other mechanisms are likely implicated in our rat model observations, and it is not known whether they are conserved in humans, as well.
We demonstrated induction of the A. baumannii phospholipase (plc2 and pld2) and basC, basD (P ϭ 0.066), and bauA genes in the presence of C. albicans (Table 1) ; basC, basD, and bauA are essential for the biosynthesis and utilization of acinetobactin, the main siderophore in A. baumannii. Furthermore, we observed induction of barB, also part of the siderophore-mediated iron acquisition system (27, 28) . Siderophores facilitate iron acquisition from the host and consequently enhance bacterial fitness and virulence, given its limited availability as free iron in mammalian tissues (28) . Therefore, the intensification of (i) iron uptake and (ii) use of carbon as a source of energy from host phosphatidylcholine breakdown by Acinetobacter phospholipases (29) are potential mechanisms through which C. albicans enhances the ability of A. baumannii to cause pneumonia. On the other hand, suppression of the ompA and abaI genes could be indicative of an antagonistic relationship between the two organisms. The ompA product has been found to adhere to hyphae, inhibiting C. albicans growth (17) , whereas abaI encodes an autoinducer synthase that contributes to quorum sensing and biofilm formation (30, 31) .
Our study has limitations that should be taken into consideration and addressed in future experiments. First, we used only one A. baumannii and one C. albicans strain. Also, we studied a model of acute infection in previously healthy animals, and it is difficult to draw firm conclusions that will be applicable to intensive care unit (ICU) patients, who are frequently immunosuppressed, are hospitalized for days or weeks, have structural lung abnormalities, and have received multiple antibiotics. Third, we studied cytokine levels in lung homogenate tissue, consisting of diverse immune and other cell populations. Fourth, we assessed only the shortterm in vitro effect of A. baumannii coincubation with C. albicans on the expression of A. baumannii virulence genes, which might not adequately simulate the complex in vivo bacterial-yeast interactions in the setting of chronic airway colonization and biofilm physiology. Notably, though, in a recent clinical study of 618 intubated patients, we found that Candida colonization was significantly associated with the subsequent development of A. baumannii ventilator-associated pneumonia, after robust adjustment for all other confounders and propensity score matching (32) .
In conclusion, we found that respiratory tract colonization with C. albicans facilitated the development of A. baumannii pneumonia in a rat model by modulating the expression of A. baumannii virulence genes and/or through modification of the host immune response. In the setting of established Candida colonization, antifungal treatment lowered the incidence of A. baumannii pneumonia, potentially by suppressing IFN-␥ production and enhancing IL-17 production. Prospective clinical studies on the association between Candida sp. airway colonization, preemptive antifungal treatment, and subsequent A. baumannii ventilator-associated pneumonia should be considered. 
ACKNOWLEDGMENTS
